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A CXCR4/CD4 Pseudotype Rhabdovirus
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Teshome Mebatsion, Stefan Finke, Frank Weiland, proteins on their surface, was so far not feasible. Such
an approach was until recently confined to retroviruses,and Karl-Klaus Conzelmann*
Department of Clinical Virology which in the absence of their own spike protein accomo-
date a variety of foreign membrane proteins, such asFederal Research Center for Virus Diseases
of Animals CD4 (Young et al., 1990), to produce pseudotype vi-
ruses. By applying a system that allows recovery ofPaul-Ehrlich-Straûe 28
72076 TuÈ bingen genetically altered negative strand RNA viruses from
cDNA (Schnell et al., 1994; reviewed in Conzelmann andGermany
Meyers, 1996), we recently found that a rhabdovirus,
rabies virus (RV), is also able to form ªspikeless,º nonin-
fectious virus particles (Mebatsion et al., 1996a), sug-Summary
gesting the possibility of generating pseudotype viruses
with an altered receptor specificity. Mammalian rhab-We show that a cellular virus receptor functions in the
doviruses replicate in the cytoplasm of infected cells.envelope of a virus, allowing selective infection of cells
Virus budding takes place at the cell surface where thedisplaying the receptor ligand. A G-deficient rabies
viral ribonucleoprotein complex (RNP or nucleocapsid)virus (RV) pseudotyped with CD4- and CXCR4-derived
is enwrapped into an envelope containing an internalproteins selectively infected cells expressing HIV-1 en-
matrix protein (M) and trimeric spikes, which are com-velope protein. Envelope protein or CD4 antibodies
posed of a type I membrane glycoprotein (G) and whichblocked virus entry. Pseudotype virus formation was
mediate entry into target cells by receptor-mediatedmost efficient with chimeric receptor proteins pos-
endocytosis (reviewed in Wagner and Rose, 1996). Thesessing the cytoplasmic tail of the RV G spike protein
carboxy-terminal cytoplasmic domain of RV G was(CXCR4-RV and CD4-RV). While CXCR4-RV was incor-
found to contain a signal that allows efficient sorting ofporated when expressed alone, CD4-RV incorporation
G protein and moreover of a chimeric HIV-1 Env proteinrequired CXCR4-RV as a carrier protein, indicating a
with a G-derived cytoplasmic tail into the virus envelopemechanism by which oligomeric surface proteins are
(Mebatsion and Conzelmann, 1996; Mebatsion et al.,sorted into the RV envelope. Viral vectors bearing virus
1996a).receptors in their envelope may be useful reagents for
We show here that a functional HIV-1 receptor com-targeting virus-infected cells in vivo.
plex composed of CD4- and CXCR4-derived proteins
can be directed into the RV envelope and that the re-Introduction
sulting rhabdoviruses selectively infect rodent or human
cells expressing HIV-1 Env. The results show thatThe presence of cell membrane proteins that act as virus
CXCR4 and CD4 are sufficient to support Env-mediatedreceptors determines whether a cell can be invaded by
fusion and that receptor signaling is not required. Mosta virus or not. Dependent on the receptor(s) chosen,
interestingly, the RV G cytoplasmic tail of a chimericsome viruses may infect nearly all mammalian cell types
CXCR4 protein (CXCR4-RV) promoted efficient incorpo-or only a small subset of cells from a certain species
ration of the protein into the virus envelope, whereas(reviewed in Wimmer, 1994). Human immunodeficiency
the G tail was not sufficient to promote detectable incor-virus type 1 (HIV-1), for example, can only infect cells
poration of a corresponding CD4 construct (CD4-RV).expressing the CD4 differentiation antigen, which serves
Upon simultaneous expression, CD4-RV was efficientlyas the primary attachment protein for the virus envelope
coincorporated with CXCR4-RV. This suggests a mech-glycoprotein (Env) (Dalgleish et al., 1984; Klatzmann et
anism by which only oligomeric protein complexes pro-al., 1984). Additional cofactors belonging to the family
viding RV G cytoplasmic tail structures are sorted intoof seven-transmembrane GTP-binding protein-coupled
budding virions. The possibility to generate novel viralreceptors arenecessary for membrane fusion and define
gene delivery vectors whose cell tropism is directed bysubsets of CD41 cells permissive for entry of particular
cellular receptor proteins provides a useful tool to studyHIV-1 strains or isolates. While the CXC chemokine re-
receptor function and membrane fusion mechanismsceptor 4 (CXCR4), or Fusin (Feng et al., 1996), acts as the
and may open novel strategies for treatment of persis-coreceptor for T cell line-tropic HIV-1 strains infecting T
tent and latent virus infections in vivo.helper cells, the CC chemokine receptor 5 (CCR5) is
the key cofactor for macrophage-tropic isolates, which
target macrophages and T helper cells (Alkhatib et al., Results
1996; Choe et al., 1996; Deng et al., 1996; Doranz et al.,
1996; Dragic et al., 1996). In previous work, a chimeric HIV-1 Env protein pos-
Exploitation of the specificity of spike/receptor inter- sessing the 44-amino-acid cytoplasmic domain of RV
actions in a reverse manner, namely by incorporating G was found to be sorted into the envelope of a
receptor proteins into the envelope of a virus in order to G-deficient RV mutant, whereas wild-type Env or pro-
target selectively virus-infected cells that display spike teins with Env-derived cytoplasmic sequences of 44
amino acids in length were excluded from incorporation
(Mebatsion and Conzelmann, 1996). The generation of*To whom correspondence may be addressed.
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Figure 1. Carboxy-Terminal Amino Acid Se-
quence of CD4 and CXCR4 Constructs
Underlined sequences indicate the putative
transmembrane-spanning domain 7 of CXCR4
and the single transmembrane anchors of
CD4 and RV G.
chimeric CD4 and CXCR4 proteins possessing the RV trans were used to infect BSR cells coexpressing
CXCR4-RV and CD4-RV from transfected plasmids.G cytoplasmic tail was therefore considered necessary.
CD4- and CXCR4-encoding cDNAs were obtained by Virions purified from cell culture supernatants by iso-
pycnic sucrose gradient centrifugation indeed con-RT-PCR from HeLa T4 cells (Maddon et al., 1986) and
were cloned in a T7 RNA polymerase promoter-con- tained additional proteins, corresponding in size and
antibody reaction to CD4-RV and CXCR4-RV (Figuretrolled expression plasmid (pT7T; Conzelmann and
Schnell, 1994). We then prepared chimeric cDNAs en- 2B). Theirdistribution in thegradient fractions correlated
with that of RV proteins, indicating true incorporation ofcoding proteins in which the RV G tail was fused to the
CD4 transmembrane anchor (CD4-RV) or to the mem-
brane-spanning domain 7 of CXCR4 (CXCR4-RV) (Figure
1). Proteins were expressed by transfection of plasmids
into baby hamster kidney cells (BHK; clone BSR) that
were infected previously with the vaccinia recombinant
vTF7-3 providing T7 RNA polymerase (Fuerst et al.,
1986). The chimeric proteins were identified on immu-
noblots with an anti-RV G serum (S 72) recognizing the
G-derived cytoplasmic tail of the proteins. In extracts
from cells transfected with the CXCR4-RV-encoding
plasmid, a protein species of an apparent relative molec-
ular weight of 37 to 40 kDa was identified (Figure 2A).
In addition, heterogenoushigh molecularweight species
were observed, which is apparently typical for chemo-
kine receptors (Liu et al., 1996). CD4-RV possessed an
apparent molecular weight of 55 kDa, similar to that
of wild-type CD4 (Figure 2A). As determined by FACS
analyses with the anti-CXCR4 MAb 12G5 (Endres et al.,
1996) and the anti-CD4 MAb Q4120 (Healey et al., 1990),
the levels of cell surfaceexpression were nearly identical
for wild-type and chimeric proteins, both after separate
expression and coexpression of all possible combina-
tions (data not shown).
Transient coexpression of the chimeric proteins al-
lowed BSR cells to undergo Env-mediated fusion. After
mixing of cells coexpressing CD4-RV and CXCR4-RV or
combinations of wild-type and chimeric proteins with
cells that were transfected with a plasmid encoding HIV-
1(NL4-3) Env, formation of syncytia was observed. The
fusion reaction depended on coexpression of CXCR4
and CD4 constructs and the presence of Env on the
target cells. No syncytia were observed after mixing
of CD4-RV and CXCR4-RV-expressing cells with cells
expressing fusion proteins from other viruses such as
RV G or measles virus fusion protein (F). The chimeric
proteins were not only able to substitute accurately for
Figure 2. Identification of Chimeric Proteins in Cell Extracts andauthentic CD4 and CXCR4 proteins in Env-mediated
Density Gradient-Purified Virionscell±cell fusion but also rendered BSR cells permissive
(A) CD4-RV and CXCR4-RV were detected in extracts of transfectedfor infection with the previously described RV (HIV-1-
BSR cells after reducing SDS-PAGE and immunoblotting by probingEnv) pseudotype virus (data not shown).
with an anti-RV G rabbit serum (S72) recognizing the common cyto-
plasmic tail sequence or the anti-human CD4 MAb Q4120.
CXCR4-RV and CD4-RV Are Incorporated into (B) G-deficient RV (SAD DG) was grown in BSR cells infected with
vTF7±3 and expressing CD4-RV and CXCR4-RV from transfectedthe Envelope of Rhabdovirions
plasmids. Supernatant virions from 6 3 106 cells were harvestedTo analyze incorporation of the chimeric proteins into
24 hr posttransfection and purified by isopycnic centrifugation inthe RV envelope, we used a previously established com-
sucrose gradients. Twelve equal gradient fractions (1±12) were ana-plementation assay in which proteins expressed in trans
lyzed by immunoblotting with rabbit sera recognizing RV nucleopro-
complement a G-deficient RV mutant (SAD DG) for a tein (N), phosphoprotein (P), and matrixprotein (M) and with the
single round of infection (Mebatsion et al., 1996a). SAD anti-RV serum reactive with the G cytoplasmic tail sequence of
CXCR4-RV and CD4-RV.DG virions prepared in cells providing RV G spikes in
A Rhabdovirus Targeting HIV-1 Env-Positive Cells
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Figure 4. CD4-RV Requires a Carrier Protein for Incorporation into
the RV Envelope
SAD DG was complemented in cells expressing the indicated pro-
teins in the presence of [35S]methionine. Supernatant virions were
subjected to velocity centrifugation in 10% to 50% sucrose gradi-
ents, and fractions five to seven containing the majority of particles
(numbering is from top to bottom of the gradient) were analyzed by
SDS-PAGE. In contrast to CXCR4-RV, CD4-RV is not incorporated
into the virus envelope when expressed alone. After coexpression
with CXCR4-RV or CXCR4, both CD4-RV and CD4 are incorporated.
derived proteins, complementation experiments involv-
ing wild-type proteins and combinations of chimeric andFigure 3. The Envelope of Rhabdovirus Particles Contains CD4-RV
wild-type proteins were performed in the presence ofand CXCR4-RV
[35S]methionine. Virions were analyzed after velocityVirions complemented with CXCR4-RV and CD4-RV were purified
centrifigation in sucrose gradients. Neither CD4-RV noras described in Experimental Procedures and analyzed by electron
microscopy. The majority of particles have the typical bullet shape CD4 could be demonstrated in virus particles generated
of rhabdoviruses. Labeling of virions with anti-human CD4 MAb in cells expressing the single proteins (Figure 4A). In
Q4120 (B) or anti-CXCR4 MAb 12G5 (C) and gold-coupled anti- contrast, both wild-type CXCR4 and CXCR4-RV were
mouse IgG revealed the presence of both CD4-RV and CXCR4-RV
found incorporated. The presence of the RV G cyto-in the envelope of particles and their distribution over the entire
plasmic tail in CXCR4-RV augmented incorporation ofvirus surface. Virions in (A) were incubated with gold-coupled anti-
the protein 7-fold as compared to CXCR4. Virions ob-mouse IgG in the absence of MAbs. The bar represents 100 nm.
tained from cells expressing combinations of proteins,
however, contained both CD4- and CXCR4-derived pro-
teins (Figure 4B). CXCR4-RV and CXCR4 not only sup-the CXCR4-RV and CD4-RV into the virus envelope. This
ported incorporation of CD4-RV but also of wild-typewas directly confirmed by electron microscopy. As for
CD4, emphasizing that a direct interaction of the ectodo-the virus complemented with the autologous RV G
mains of CD4 and CXCR4 is responsible for the coin-spikes, typical bullet-shaped virions represented the
corporation of CD4-derived proteins. However, althoughmajority of particles (Figure 3). Immuno-gold staining
the RV G tail of CD4-RV is not sufficient to direct autono-with MAbs Q4120 or 12G5 revealed the presence of
mously the protein into the virus, it enhanced the effi-CD4-RV or CXCR4-RV on the surface of apparently all
ciency of coincorporation, both with CXCR4-RV andvirions and their distribution over the entire virus surface
CXCR4 (37% and 18%, respectively), as compared with(Figures 3B and 3C).
CD4 coincorporation. Taken together, the results show
that CD4-derived proteins are incorporated only in formIncorporation of CD4 Requires CXCR4
of a complex with a heterologous ªcarrierº protein. Onlyas a Carrier Protein
within such a complex is the G-derived CD4-RV cyto-In striking contrast to virions complemented with both
plasmic tail able to contribute to incorporation.CXCR4-RV and CD4-RV, virions complemented with
CD4-RV alone did not contain detectable amounts of
CD4-RV, although the levels of cell surface CD4-RV were Selective Infection of Env-Expressing Target Cells
To determine whether the rhabdovirus envelope-boundsimilar in cells expressing only CD4-RV or coexpressing
CD4-RV and CXCR4-RV, as determined by FACS. To receptor proteins could mediate infection of target cells,
pseudotype virions were used to inoculate BSR cellsspecify the requirements for incorporation of CD4-
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consistently observed in cells expressing HIV-1 Env. No
fluorescence was detected in mock-transfected cells or
after inoculation of Env-expressing cells with pseu-
dotype viruses complemented with either CXCR4-RV or
CD4-RV alone. To exclude a putative influence of Env
expression on the permissivity of cells for RNP entry or
RV gene expression, cells were also infected with virions
complemented with RV G. Regardless of Env expres-
sion, identical numbers of fluorescent cells were ob-
served. As calculated from endpoint dilution series, a
titer of 4 3 106 fluorescent cell forming units/ml was
obtained after complementation with RV G. Superna-
tants with virions complemented with CD4-RV and
CXCR4-RV gave rise to 3.8 3 103 fluorescent Env-
expressing cells/ml. Since on average only 40% to 60%
of transfected cells expressed Env, this number has to
be considered a minimal titer. Selective infectivity for
Env-expressing cells was also confirmed for virions
pseudotyped with combinations of chimeric and wild-
type proteins. Virions carrying CXCR4-RV and CD4 or
CXCR4 and CD4-RV yielded quite similar titers of 6.1 3
102 and 5.0 3 102 fluorescent cells/ml, respectively.
When the two wild-type proteins were used for comple-
mentation, 1.5 3 102 fluorescent cells/ml were deter-
mined, corresponding to a 25-fold titer decrease as
compared to virions carrying CXCR4-RV and CD4-RV.
To confirm further that the specificity of membrane
fusion parallels that of HIV-1 infection, we performed
blocking and neutralization experiments. The mono-
clonal CD4-antibody Q4120, which is able toblock HIV-1
entry into cells, completely neutralized the infectivity of
virions complemented with CD4-RV and CXCR4-RV at
a dilution of 1:50 (Figure 5B),whereas a MAbneutralizing
RV G had no effect. A strong inhibition of infection was
observed after incubation of Env-expressing target cells
with a human anti-HIV-1 IgG preparation (Figure 5B) in
contrast to human anti-RV Ig.
We extended the analyses to human target cells bear-
ing both the HIV-1 receptor and Env, thus mimicking
human HIV-1-infected target cells. HeLa T4 cells were
transfected with the NL4-3 Env-encoding plasmid and
were then incubated with RV(CD4-RV/CXCR4-RV) pseu-
dotype virions. As demonstrated by the appearance of
fluorescent syncytia after 1 day of infection, the cells
were susceptible both for fusion with each other and, in
addition, for infection with the receptor-complemented
virions (Figure 5C). As confirmed by fluorescence double
Figure 5. Virions Containing CD4-RV and CXCR4-RV Selectively In-
staining, cells not expressing Env did not form syncytiafect Env-Expressing Cells
and were not permissive for infection by pseudotype(A) Virions complemented with indicated combinations of CD4-RV
viruses.and CXCR4-RV or with RV G were used to inoculate BSR cells
transiently expressing the HIV-1 (NL4-3) Env protein (Env) or non-
transfected BSR cells (-). Compared to the RV(G) control, a 100- Discussion
fold amount of supernatant volume was used. Infection was demon-
strated by RV N protein immunofluorescence. We have utilized the elaborate fusion mechanism devel-
(B) Anti-CD4 MAb Q4120 neutralizes the infectivity of (CXCR4-RV
oped by a virus to enter a cell in a reverse manner. Anplus CD4-RV) pseudotype viruses (anti-CD4) and human anti-HIV-1
HIV-1 receptor complex made up of CD4 and CXCR4IgG blocks entry into Env-expressing BSR cells (anti-HIV).
analogs could substitute for the functions of a rhabdovi-(C) HeLa T4 cells expressing Env formed syncytia and were permis-
sive for (CXCR4-RV plus CD4-RV) pseudotype virus infection. rus spike in virus formation and in the attachment to a
target cell. In contrast to the viruses known so far, the
novel rhabdovirus does not possess any fusogenic pro-
expressing Env (NL4-3) from transfected plasmids. After tein in its envelope. Membrane fusion, resulting in infec-
an incubation of 36hr, cellswere analyzed for productive tion of the target cells, is rather initiated by cell surface
rhabdovirus infection by direct immunofluorescence mi- Env, formally rendering the lipid bilayer of the virus enve-
lope the ªtarget membraneº for fusion. Except for this,croscopy (Figure 5A). RV nucleoprotein expression was
A Rhabdovirus Targeting HIV-1 Env-Positive Cells
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the mechanism of membrane fusion parallels that ob- ªdocking stationsº might allow retention of a preformed
complex made up of multiple tails more efficiently thanserved for HIV-1 infection. The Env protein of a T cell
line-tropic HIV-1 was absolutely required on the cell of single tails and thus favor sorting of ªcorrectº oligo-
meric spike proteins into the envelope. So far, we favorsurface, and both CD4 and CXCR4 were necessary on
the virus surface. Antibodies against CD4 or Env that a model in which sorting of spike proteins is achieved
concomitantly to the virus budding process. Accord-are known to inhibit HIV-1 infection neutralized the in-
fectivity of the pseudotype virus or inhibited entry into ingly, the budding virus core can be imagined as one-
half of a three-dimensional zipper, where the dockingtarget cells by blocking the cellular ªreceptor,º respec-
tively. The described system thus represents a versatile stations of the core accomodate and retain well-fitting
counterparts represented by the cytoplasmic tail struc-and, due to the use of defective viruses, a safe ªreverseº
model to study factors involved in HIV-1 entry. ture of membrane proteins.
In addition to the RV G tail of CXCR4-RV, three cyto-The exact mechanism of how chemokine receptors
facilitate membrane fusion is not yet known. They are plasmic loops of 15 to 22 amino acids in length may
protrude at the inner side of the envelope membraneable to bind Env directly (Atchison et al., 1996; Lapham
et al., 1996; Rucker et al., 1996; Trkola et al., 1996; Wu without interfering with incorporation mediated by the
cytoplasmic tail. As observed with mutants of thechime-et al., 1996) and, in conjunction with CD4, trigger the
conformational changes required for exposition of the ric Env-RV protein, the exact length of the cytoplasmic
tail is not that crucial for incorporation, allowing a mem-fusion peptide of the Env subunit gp41 (Chan et al.,
1997, Weissenhorn et al., 1997). In view of the natural brane-proximal insertion of at least six amino acids with-
out reducing the incorporation rate (unpublished data).function of chemokine receptors, a putative role in HIV
entry of GTP protein-mediated responses, such as Ca21 Thus, in addition to specific docking sites, some extra
space may be available between the envelope mem-influx and depolarization of the membrane, could not
be excluded. The present results demonstrate that sig- brane and the internal virus core structure, accomodat-
ing cytoplasmic loop residues of CXCR4-RV. As indi-naling to GTP-binding proteins is not required for Env-
mediated membrane fusion, since CXCR4-RV lacks the cated both by infectious virus titers and direct analysis
of incorporated proteins, the CXCR4-RV/CD4-RV com-entire CXCR4 cytoplasmic tail, which is most probably
the domain required for signaling (Franci et al., 1996). plex is obviously favored over the CXCR4-RV/CD4 com-
plex, most likely through the presence of homogenousMoreover, the presence of trimeric GTP-binding pro-
teins and other factors required for energy-dependent tails fitting well into docking sites. In the case of CXCR4-
RV/CD4, the CD4 cytoplasmic domain might be acco-signaling in the envelope of pseudotype virions can be
excluded. Corresponding results have also been ob- modated either nonspecifically in the docking site or in
the additional nonspecific extra space.tained for chimeric CCR5 proteins, which were unable
to signal but supported HIV-1 entry efficiently (Atchison The observed weak incorporation of wild-type CXCR4,
when expressed alone, might be due to some extent toet al., 1996). In addition, since it is very unlikely that
pseudotype virions contain residual membrane or cyto- the availability of the nonspecific extra space, accom-
modating the 45 amino acids of the CXCR4 cytoplasmicplasmic cell proteins that might be involved in HIV-1
receptor function and fusion, this also strongly indicates tail in addition to the intracellular loops. So far, however,
it cannot be excluded that the CXCR4 tail may have athat CXCR4 and CD4 are indeed sufficient to promote
Env-mediated membrane fusion. three-dimensional structure resembling that of RV G tail,
fitting into specific docking spaces.The failure of CD4-RV in incorporation into the RV
envelope, in contrast to other proteins such as CXCR4- The present findings emphasize that major differ-
ences may exist in the assembly of closely related rhab-RV, Env-RV, or RV G, revealed that in addition to the RV
G tail other factors are important for sorting of proteins doviruses. Nonspecific incorporation of various mem-
brane proteins, including the monomeric CD4, into theinto budding RV. While CD4 is present as a monomeric
molecule on the cell surface (Kwong et al., 1990), Env envelope of vesicular stomatitis virus (VSV) has been
reported (Schubert et al., 1992; Schnell et al., 1996a).or RV G form noncovalently linked trimers (Whitt et al.,
1991; Gaudin et al., 1992; Chan et al., 1997; Weissenhorn CD4 and a CD4 chimera with the VSV G transmembrane
and cytoplasmic tail were found incorporated with theet al., 1997). It therefore appears that only multimeric
proteins containing the RV G tail are directed into the same efficiency, suggesting that neither specific signals
nor formation of protein oligomers are required for incor-viral envelope. The efficient incorporation of CXCR4-RV
and of CD4-RV together with CXCR4-RV suggests that poration of proteins into the VSV envelope.
We have shown here that rather selective incorpora-CXCR4-RV homo-oligomers and CXCR4-RV/CD4-RV
hetero-oligomers are present on the cell surface. Actu- tion of a functional HIV-1 receptor complex into the
envelope of a rhabdovirus can be achieved and thatally, CD4 and CXCR4 can be coprecipitated in the ab-
sence of Env (Lapham et al., 1996), directly demonstra- specific targeting of HIV-1 Env-expressing cells with this
virus is possible. Given the high structural similarity ofting an interaction of the two proteins. The successful
coincorporation of both wild-type CD4 and CD4-RV with the members of the chemokine receptor familiy (for a
recent review, see Murphy, 1996), it appears likely thatCXCR4-constructs indicates that the ectodomain of
CD4 is responsible for the interaction. pseudotype rhabdoviruses carrying coreceptors for
macrophage-tropic HIV-1 variants such as CCR5 or car-A mechanism allowing selective incorporation of
multimers most likely involves the necessity to present rying both CXCR4 and CCR5 can be prepared in the
future. Since foreign genes are retained very stably in theseveral RV G cytoplasmic tails in the form of a close
association in order to fit to defined structures of internal absence of selection (Mebatsion et al., 1996b; Schnell
et al., 1996b), generation of high titered recombinantvirus proteins. The three-dimensional space of such
Cell
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from 12 equal gradient fractionswere resolved by SDS-PAGE, trans-rhabdoviruses expressing HIV receptors in cis is also
ferred to nitrocellulose membranes, and incubated with a mixturepossible. Further investigations will reveal whether gene
of rabbit sera directed against RV proteins as described previouslydelivery vectors based on cytopathic rhabdovirus mu-
(Mebatsion et al., 1996a). Proteins were visualized after incubation
tants have a practical utility in targeting and elimination with peroxidase-conjugated goat anti-rabbit IgG (Dianova) by using
of HIV-1 infected cells in vivo and whether they may the Enhanced Chemiluminescence (ECL) Western blot detection kit
(Amersham; 1 min incubation) and exposure to X-ray films (Biomaxhelp to decrease virus load.
MR, Kodak).
For radioactive labeling of virions, 2 3 106 cells infected with SAD
Experimental Procedures
DG were superinfected with vTF7-3 and transfected with plasmids
as described above. Six hours after transfection, cells were incu-
Construction of Plasmids bated with 100 mCi [35S]methionine (1,365 Ci/mmol; ICN) for 36 hr.
CXCR4 and CD4 cDNA was obtained by RT-PCR of total mRNA Supernatant virions were prepurified by centrifugation through 20%
from HeLa T4 cells with primers fu11 (59-cacgaattcaacccctacaATG sucrose at 30,000 rpm in a TLA45 rotor for 1 hr. The pellet was
GAGGGGATCAGTATATAC-39) and fu2rev (59-gtggaattcaagcttctgtg resuspended in TEN and centrifuged in a continuous 10% to 50%
TTAGCTGGAGTGAAAACTTG-39) or primers CD4.11 (59-gacgaattcc sucrose gradient in a SW41 rotor at 27,000 rpm for 1 hr. Twelve
acaATGAACCGGGGAGTCCCTT-39) and CD4.2rev (59-gacgaattctcg equal gradient fractions were processed for SDS-PAGE as de-
tgccTCAAATGGGGCTACATGTCT-39). cDNAs were cloned in pT7T scribed above. RV N protein was used as an internal standard for
(Conzelmann and Schnell, 1994), resulting in pT7TFu and pT7TCD4. phosphorimager (FujiBAS1500) quantitation.
The plasmid encoding CXCR4-RV (pT7TFu7cd) was made by blunt
end insertion of a PstI-DraI 1 kb fragment from pT7TFu into the
Immunoelectron MicroscopyAsuII site of pHIVE, which contains the sequence encoding the RV
Supernatant virions from 5 3 106 transfected BSR cells were fixedG cytoplasmic tail. For generation of pT7TCD4-RV, the AsuII-EcoRI
with 0.5% glutaraldehyde for 30 min at 48C and purified by pelletingfragment of pHIVE was used to replace an AsuII-EcoRI fragment of
through 20% sucrose on a 60% sucrose cushion. The interphasepT7TCD4.
was collected by side puncture. Carbon-coated nickel grids were
deposited for 7 min on a drop of the virus suspension, washed four
Protein Expression, Cell Fusion, and Virus times with PBS [pH 7.4] containing 0.5% BSA, and incubated for
Complementation Assays 45 min on a solution of MAb Q4120 or 12G5 (R and D systems).
Cell fusion assays and virus complementation were done as de- After additional washings, grids were deposited for 45 min on a goat
scribed previously (Mebatsion and Conzelmann, 1996) in BHK cells anti-mouse IgG antibody coupled to 10 nm gold particles (Biocell,
(clone BSR) infected with vTF7-3 (Fuerst et al., 1986) at a multiplicity Cardiff). After washing with PBS and distilled water, samples were
of infection (moi) of 5. Five micrograms of each protein-encoding negative stained with 1% uranyl acetate (unbuffered) and examined
plasmid were transfected 1 hr postinfection using CaPO4 (Stra- in a Zeiss 109 electron microscope. Micrographs were taken at an
tagene). For cell fusion analysis, cells were trypsinized 5 hr postin- instrumental magnification of 50,0003 on Agfa Scientia 23D56 film.
fection and mixed with equal numbers of cells transfected with 5
mg of plasmids encoding either HIV-1(NL4-3)-Env, RV G (strain SAD
Acknowledgments
B19; Conzelmann et al., 1990), or measlesvirus F (Edmonston strain;
kindly provided by M. Billeter and R. Cattaneo). Formation of syncy-
We thank V. Schlatt, K. Kegreib, and K. Mildner for perfect technicaltia was monitored after cocultivation for 14 hr.
assistance, A. SaalmuÈ ller for performing FACS analyses, and G.For virus complementation, BSR cells were infected at an moi of
Meyers for reading the manuscript. HeLa T4 cells, human HIV-1 Ig,1 with SAD DG lacking the entire G gene (Mebatsion et al., 1996a)and
and CD4 MAb Q4120 were obtained through the AIDS Researchthat had been phenotypically complemented with RV G as described
and Reference Reagent Program, NIH. For contributions of various(Mebatsion and Conzelmann,1996). After overnight incubation, cells
sorts we thank M. Alizon, P. Clapham, R. Ellerbrock, R. Kurth, andwere superinfected with vTF7-3 and transfected with plasmids as
A. Werner. This work was supported by grant BEO/0311171 fromdescribed above. Supernatants were harvested at 1 to 2 days post-
the Bundesministerium fuÈ r Bildung, Wissenschaft, Forschung undtransfection and used for virus purification or inoculation of 3.2
Technologie.cm diameter dishes of confluent BSR cell monolayers (106 cells)
expressing either Env, RV G, measles virus F, or mock-transfected
Received February 12, 1997; revised July 28, 1997.cell cultures. RV N expression was analyzed after fixing cells with
80% acetone and staining with an FITC conjugate (Centocor) after
24 hr (HeLa cells)or 36 hr (BSR cells).Double staining was performed References
with an anti-RV N MAb and human anti-HIV-1 IgG (Prince et al.,
1991) followed by incubation with rhodamine (TRITC)-conjugated Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E.,
goat anti-mouse IgG and FITC-conjugated goat anti-human IgG Murphy, P.M., and Berger, E.A. (1996). CC CKR5: a RANTES, MIP-
(Dianova). Cell surface expression of CD4 and CXCR4 constructs 1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic
was determined by FACS (FACStar) with MAbs Q4120 and 12G5 HIV-1. Science 272, 1955±1958.
and phycoerythrin-coupled conjugates. For virus neutralization, cell Atchison, R.E., Gosling, J., Monteclaro, F.S., Franci, C., Digilio, L.,
culture supernatants were incubated with the anti-CD4 MAb Q4120 Charo, I.F., and Goldsmith, M.A. (1996). Multiple extracellular ele-
(Healey et al., 1990) at a dilution of 1:50 for 1 hr at 378C. Target cells ments of CCR5 and HIV-1 entry: dissociation from response to
were incubated in culture medium with anti-HIV-1 IgG or human chemokines. Science 274, 1924±1926.
anti-RV Ig (Behring) at a dilution of 1:20 for 1 hr prior to inoculation
Chan, D.C., Fass, D., Berger, J.M., and Kim, P.S. (1997). Core struc-
with pseudotype viruses. Subsequently, the medium volumes were
ture of gp41 from the HIV envelope protein. Cell 89, 263±273.
adjusted to obtain an antibody dilution of 1:40. Infection of target
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D.,cells was monitored after 36 hr (BHK cells) or 24 hr (HeLa cells)
Wu, L., Mackay, C.R., LaRosa, G., Newman, W., et al. (1996). Thepostinfection.
b-chemokine receptors CCR3 and CCR5 facilitate infection by pri-
mary HIV-1 isolates. Cell 85, 1135±1148.
Virus Purification and Protein Analysis
Conzelmann, K.K., and Meyers, G. (1996). Genetic engineering ofSupernatant virions from 6 3 106 cells were prepurified by centrifu-
RNA viruses. Trends Microbiol. 4, 386±393.gation through 20% sucrose on a 60% sucrose cushion in a Beck-
Conzelmann, K.-K., and Schnell, M. (1994). Rescue of synthetic ra-man SW41 rotor at 19,000 rpm. The interphase was layered on a
bies virus genome analogs by plasmid encoded proteins. J. Virol.continuous 10% to 70% sucrose gradient prepared in TEN buffer
68, 713±719.(10 mM Tris [pH 7.4], 1 mM EDTA, 50 mM NaCl) and centrifuged in
an SW41 rotor at 35,000 rpm (210,000 3 g) for 18 hr. Virus proteins Conzelmann, K.-K., Cox, J.H., Schneider, L.G., and Thiel, H.-J.
A Rhabdovirus Targeting HIV-1 Env-Positive Cells
847
(1990). Molecular cloning and complete nucleotide sequence of the Mebatsion, T., Schnell, M.J., Cox, J.H., Finke, S., and Conzelmann,
attenuated rabies virus SAD B19. Virology 175, 485±499. K.K. (1996b). Highly stable expression of a foreign gene from rabies
virus vectors. Proc. Natl. Acad. Sci. USA 93, 7310±7314.Dalgleish, A.G., Beverly, P.C., Clapham, P.R., Crawford, D.H.,
Greaves, M.F., and Weiss, R.A. (1984). The CD4 (T4) antigen is an Murphy, P.M. (1996). Chemokine receptors: structure, function and
essential component of the receptor for the AIDS retrovirus. Nature role in microbial pathogens. Cytokine Growth Factor Rev. 7, 47±64.
312, 763±767. Prince, A.M., Reesink, H., Pascual, D., Horowitz, B., Hewlett, I.,
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Murthy, K.K., Cobb, K.E., and Eichberg, J.W. (1991). Prevention of
Di Marizo, P., Marmon, S., Sutton, R.E., Hill., C.M., et al. (1996). HIV infection by passive immunization with HIV immunoglobulin.
Identification of a major coreceptor for primary isolates of HIV-1. AIDS Res. Hum. Retroviruses 7, 971±973.
Nature 381, 661±666. Rucker, J, Samson, M., Doranz, B.J., Libert, F., Berson, J.F., Yi, Y.,
Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, Smyth, R.J., Collman, R.G., Broder, C.C., Vassart, G., et al. (1996).
S.C., Parmentier, M., Collman, R.G., and Doms, R.W. (1996). A dual- Regions in b-chemokine receptors CCR5 and CCR2b that determine
tropic primary HIV-1 isolate that uses Fusin and the b-chemokine HIV-1 cofactor specificity. Cell 87, 437±446.
receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, Schnell, M.J., Mebatsion, T., and Conzelmann, K.-K. (1994). Infec-
1149±1158. tious rabies viruses from cloned cDNA. EMBO J. 13, 4195±4203.
Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Naga- Schnell, M., Buonocore, L., Kretzschmar, E., Johnson, E., and Rose,
shima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, L.P.,
J.K. (1996a). Foreign glycoproteins expressed from recombinant
and Paxton, W.A. (1996). HIV-1 entry into CD41 cells is mediated
vesicular stomatitis viruses are incorporated efficiently into virusby the chemokine receptor CC-CKR-5. Nature 381, 667±673.
particles. Proc. Natl. Acad. Sci. USA 93, 11359±11365.
Endres, M.J., Clapham, P.R., Marsh, M., Ahuja, M., Turner, J.D.,
Schnell, M., Buonocore, L., Whitt, M.A., and Rose, J.K. (1996b). TheMcKnight, A., Thomas, J.F., Stoebenau-Haggarty, B., Choe, S.,
minimal conserved transcription stop-start signal promotes stableVance, P.J., et al. (1996). CD4-independent infection by HIV-2 is
expression of a foreign gene in vesicular stomatitis virus. J. Virol.mediated by Fusin/CXCR4. Cell 87, 745±756.
70, 2318±2323.
Feng, Y., Broder, C.C., Kennedy, P.E., and Berger, E.A. (1996). HIV-1
Schubert, M., Joshi, B., Blondel, D., and Harmison, G.G. (1992).entry cofactor: functional cDNA cloning of a seven transmembrane,
Insertion of the human immunodeficiency virus CD4 receptor intoG protein-coupled receptor. Science 272, 872±877.
the envelope of vesicular stomatitis virus particles. J. Virol. 66, 1579±
Franci, C., Gosling, J., Tsou, C.L., Coughlin, S.R., and Charo, I.F. 1589.
(1996). Phosphorylation by a G protein-coupled kinase inhibits sig-
Trkola, A., Dragic, T., Arthos, J., Binley, J.M., Olson, W.C., Allaway,naling and promotes internalization of the monocyte chemoattrac-
G.P., Cheng-Mayer, C., Robinson, J., Maddon, P.J., and Moore, J.P.tant protein-1 receptor. Critical role of carboxyl-tail serines/threo-
(1996). CD4-dependent, antibody-sensitive interactions betweennines in receptor function. J. Immunol. 157, 5606±5612.
HIV-1 and his coreceptor CCR-5. Nature 384, 184±187.Fuerst, T.R., Niles, E.G., Studier, F.W., and Moss, B. (1986). Eukary-
Wagner, R.R., and Rose, J.K. (1996). Rhabdoviridae: the viruses andotic transient expression system based on recombinant vaccinia
their replication. In Fields Virology, B. Fields, D.M. Knipe, and P.M.virus that synthesizes bacteriophage T7 RNA polymerase. Proc.
Howley, eds. (Philadelphia, Lippincott-Raven), pp. 1121±1136.Natl. Acad. Sci. USA 83, 8122±8126.
Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J., and Wiley,Gaudin, Y., Ruigrok, R.W.H., Tuffereau, C., Knossow, M., and Fla-
D.C. (1997). Atomic structure of the ectodomain from HIV-1 gp41.mand, A. (1992). Rabies virus glycoprotein is a trimer. Virology 187,
Nature 387, 426±430.627±632.
Whitt, M.A., Buonocore, L., Prehaud, C., andRose, J.K. (1991). Mem-Healey, D., Dianda, L., Moore, J.P., McDougal, J.S., Moore, M.J.,
brane fusion activity, oligomerization and assembly of the rabiesEstess, P., Buck, D., Kwong, P.D., Beverly, P.C.L., and Sattentau,
Q.J. (1990). Novel anti-CD4 monoclonal antibodies separate human virus glycoprotein. Virology 185, 681±688.
immunodeficiency virus infection and fusion of CD41 cells from virus Wimmer, E., ed. (1994). Cellular Receptors for Animal Viruses (Cold
binding. J. Exp. Med. 172, 1233±1242. Spring Harbor: Cold Spring Harbor Laboratory Press).
Klatzmann, D.E., Champagne, S., Chamaret, S., Gruest, J., Guetard, Wu, L., Gerard, N.P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N.,
D., Hercend, T., Gluckman, J.C., and Montagnier, L. (1984). T lym- Borsetti, A., Cardoso, A.A., Desjardin, E., Newman, W., et al. (1996).
phocyte T4 molecule behaves as the receptor for human retrovirus CD4-induced interaction of primary HIV-1 gp120 glycoproteins with
LAV. Nature 312, 767±768. the chemokine receptor CCR-5. Nature 384, 179±183.
Kwong, P.D., Ryu, S.E., Hendrickson, W.A., Axel, R., Sweet, R.M., Young, J.A.T., Bates, P., Willert, K., and Varmus, H.E. (1990). Efficient
Folena-Wassermann, G., Hensley, P., and Sweet, R.W. (1990). Mo- incorporation of human CD4 protein into avian leukosis virus parti-
lecular characteristics of recombinant human CD4 as deduced from cles. Science 250, 1421±1423.
polymorphic crystals. Proc. Natl. Acad. Sci. USA 87, 6423±6427.
Lapham, C.K., Ouyang, J., Chandrasekhar, B., Nguyen, N.Y., Dimi-
trov, D.S., and Golding, H. (1996). Evidence of cell-surface associa-
tion between fusin and the CD4-gp 120 complex in human cell lines.
Science 274, 602±605.
Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk,
R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., and Landau, N.R.
(1996). Homozygous defect in HIV-1 coreceptor accounts for resis-
tance of some multiply exposed individuals to HIV-1 infection. Cell
86, 367±377.
Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R.,
Weiss, R.A., and Axel, R. (1986). The T4 gene encodes the AIDS
virus receptor and is expressed in the immune system and the brain.
Cell 47, 333±348.
Mebatsion, T., and Conzelmann, K.K. (1996). Specific infection of
CD41 target cells by recombinant rabies virus pseudotypes carrying
the HIV-1 envelope spike protein. Proc. Natl. Acad. Sci. USA 93,
11366±11370.
Mebatsion, T., KoÈ nig, M., and Conzelmann, K.K. (1996a). Budding
of rabies virus particles in the absence of the spike glycoprotein.
Cell 84, 941±951.
